Another example of promising strategies to tackle the COVID‐19 outbreak is provided by an immunoinformatic analysis, which highlighted 13 Major Histocompatibility Complex‐(MHC) I and 3 MHC‐II epitopes within the spike glycoprotein of SARS‐COV‐2 that could be ideal candidates to formulate an immunogenic multi‐epitopic peptide vaccine against SARS‐COV‐249. This evidence concerns the gene CHMP5 and COVID-19.